Europe reviews Valneva's chikungunya vaccine after reports of serious side effects
(Reuters) -The European Union’s health regulator said on Wednesday it was reviewing French drugmaker Valneva’s chikungunya vaccine after reports of serious side effects in older adults. The European Medicines Agency’s (EMA) safety committee has recommended …